Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Bernal-Mondragón C et al. | 2016 | animal, rat/Wistar, whole body | magnetic field, 50/60 Hz | 1 mT |
Mahmoudinasab H et al. | 2016 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) | magnetic field, 50/60 Hz | 0.25–0.5 mT |
Sanie-Jahromi F et al. | 2016 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 0.25–0.5 mT |
Zhou L et al. | 2016 | animal, rat/Sprague Dawley, whole body | magnetic field, 50/60 Hz | 100 µT |
Lin KW et al. | 2016 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/SB34 | RF, microwaves, electric field, magnetic field, 50/60 Hz | 6 mT |
Xie YF et al. | 2016 | intact cell/cell culture, rat calvarial osteoblasts | magnetic field, signals/pulses, 50/60 Hz | 0.6 mT |
Kim YM et al. | 2016 | intact cell/cell culture, B16F10 (murine melanoma cells) | magnetic field, low frequency, signals/pulses, 50/60 Hz | - |
Moraveji M et al. | 2016 | intact cell/cell culture, human dermal papilla mesenchymal cells | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 1 mT |
Calabro E | 2016 | intact cell/cell culture, SH-SY5Y cells (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 1 mT |
Kitaoka K et al. | 2016 | intact cell/cell culture, mouse adrenal cortex-derived cells (Y-1) and human adrenal cortex-derived cells (H295R) | magnetic field, 50/60 Hz | 0.25–3 mT |
Jiang Y et al. | 2016 | animal, rat/Sprague Dawley | magnetic field, signals/pulses, 50/60 Hz | 4 mT |
Urnukhsaikhan E et al. | 2016 | intact cell/cell culture, human bone marrow-derived mesenchymal stem cells (hBM-MSCs) | magnetic field, signals/pulses, 50/60 Hz | 10 mT |
Feng B et al. | 2016 | intact cell/cell culture, human amniotic epithelial cells | magnetic field, 50/60 Hz | 4 mT |
Liu Y et al. | 2016 | intact cell/cell culture, GC-2 cells (murine spermatocyte-derived cell line) | magnetic field, 50/60 Hz | 1–3 mT |
Zhu H et al. | 2016 | intact cell/cell culture, human fetal scleral fibroblasts | magnetic field, 50/60 Hz | 0.1–1 mT |
Lee YJ et al. | 2015 | intact cell/cell culture, human bone marrow-derived mesenchymal stem cells (hBM-MSCs) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Miyata H et al. | 2015 | intact cell/cell culture, human umbilical vein endothelial cells (HUVEC) | magnetic field, 50/60 Hz | 100 µT |
Ardeshirylajimi A et al. | 2015 | intact cell/cell culture, human induced pluripotent stem cells | magnetic field, signals/pulses, 50/60 Hz | 1.5 mT |
Liu Y et al. | 2015 | intact cell/cell culture, GC-2 cells (murine spermatocyte-derived cell line) | magnetic field, 50/60 Hz | 1–3 mT |
Patruno A et al. | 2015 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Liu Y et al. | 2015 | intact cell/cell culture, GC-2 cells (murine spermatocyte-derived cell line) | magnetic field, 50/60 Hz | 1–3 mT |
Lee HC et al. | 2015 | intact cell/cell culture, MCF10 A (human breast epithelial cell line), MCF7 (human breast cancer cell line), Jurkat cells (human lymphoblastoid T cell line), NIH3T3 (mouse embryonic fibroblast cell line) | magnetic field, 50/60 Hz | 0.1–2 mT |
Manzella N et al. | 2015 | intact cell/cell culture, HuDe cells (human dermal fibroblasts) | magnetic field, 50/60 Hz | 0.1 mT |
D'Angelo C et al. | 2015 | intact cell/cell culture, HaCaT cells (human keratinocytes), SH-SY5Y cells (human neuroblastoma cell line),THP-1 cells (human monocytic leukemia cell line), K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 1 mT |
Patruno A et al. | 2015 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.